Milton J. Wallace, Director at Catalyst Pharmaceutical Partners, Inc. (CPRX), bought 23,900 shares at $0.69 ($16K) on 2010-03-04, disclosed to the SEC on 2010-03-05.
Open-market purchase of $16k CPRX by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.67 | 1,400 | $938 | 5.7% |
| 2 | $0.69 | 22,500 | $16K | 94.3% |
| Total | $0.69 avg | 23,900 | $16K | 100% |
| Filing → |
| CPRX | BUY | 2012-05-29 | $100K | — | Filing → |
| IPII | BUY | 2011-08-18 | $1K | — | Filing → |
| IPII | BUY | 2011-06-02 | $340 | — | Filing → |